Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
---|
02/08/2001 | CA2391267A1 Chemokine receptor antagonists and methods of use therefor |
02/07/2001 | EP1073654A1 2,3-olefinic epothilone derivatives |
02/07/2001 | EP1073648A1 12,13-Modified epothilone derivatives |
02/07/2001 | EP1073647A1 12,13-cyclopropane epothilone derivatives |
02/06/2001 | US6184378 Pigments, laser dyes and precursors for preparing fluorescent dyes, polymeric colorants, |
02/01/2001 | WO2001007439A2 Process for the production of epothiolone b and derivatives as well as intermediate products for this process |
02/01/2001 | WO2001007406A1 Novel amide derivatives |
02/01/2001 | WO2001007040A1 Multidrug-resistant cancer overcoming agents and process for producing the same |
01/31/2001 | EP1071676A1 Kinetic resolution of olefins |
01/31/2001 | EP0975620A4 Novel synthesis of myo-inositol phosphates |
01/31/2001 | CN1281859A Microwave extracting method of artemisine |
01/31/2001 | CN1281858A Chiral compounds and application of them as chiral doping agent in production of cholesterol type liquid crystal composite |
01/31/2001 | CN1281856A Microwave extraction method of ginkgolic flavone and bilobalide-like substances |
01/30/2001 | US6180105 Method for producing an extract containing artemesinin |
01/25/2001 | WO2001005769A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
01/25/2001 | WO2001005398A1 Phosphate transport inhibitors |
01/25/2001 | WO2000066587A3 Polyamines and their use in therapy |
01/25/2001 | CA2379657A1 Phosphate transport inhibitors |
01/24/2001 | EP1070069A1 Bicyclic hydroxamic acid derivatives |
01/24/2001 | CN1061043C Benzo-iso-thiazolyl substituted amino methyl benzodipyran |
01/24/2001 | CN1061040C 3-aryl-4-hydroxy-delta 3-dihydrofuranone derivatives, its preparing process, pesticide containing same and use |
01/23/2001 | US6177457 Cyclization of chemical intermediates; fungicides |
01/23/2001 | US6177424 4′-Substituted-4′,5′-dihydropsoralens and therapeutical uses thereof |
01/18/2001 | WO2001004123A2 Peroxide-based antimalarial compounds |
01/18/2001 | WO2001004107A1 SUBSTITUTED α,β-ANELLATED BUTYROLACTONES |
01/18/2001 | WO1999064049A9 Novel antibacterial agents |
01/17/2001 | EP1069121A1 Reagent for singlet oxygen determination |
01/17/2001 | EP1068180A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
01/17/2001 | EP1067965A1 Pharmaceutical composition for treating cerebral apoplexy and craniocerebral trauma |
01/17/2001 | EP1067923A1 2-aroyl-4-acyl paclitaxel (taxol) analogs |
01/17/2001 | EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds |
01/17/2001 | CN1280560A Adamantane derivatives |
01/17/2001 | CN1280499A Use of ginkgo biloba extracts for preparing a medicine |
01/17/2001 | CN1060777C Synthetic method for aromatic spiral double lactones |
01/16/2001 | US6174889 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
01/16/2001 | US6174710 Treating a mammal suffering from helicobacter pylori disorder by administering spirolaxine or derivative with a h2 blocker or proton pump inhibitor |
01/11/2001 | WO2001002408A1 Novel xanthone compounds, their preparation and use as medicament |
01/11/2001 | WO2001002407A2 Taxane derivatives and processes for the preparation thereof |
01/11/2001 | WO2001002384A1 Spirofluorenopyrans |
01/11/2001 | WO2001002382A1 Hydrophobic, high tg cycloaliphatic epoxy resins |
01/11/2001 | WO2001001968A2 Methods and compositions for regulating gut motility and food intake |
01/11/2001 | DE19931709A1 Neue tetracyclische Acetale Novel tetracyclic acetals |
01/11/2001 | CA2376681A1 Novel xanthone compounds, their preparation and use as medicament |
01/11/2001 | CA2374358A1 Methods and compositions for regulating gut motility and food intake |
01/10/2001 | EP1067126A2 Tetracyclic acetals |
01/10/2001 | EP1066042A2 Steroidal saponins for treating alzheimer's disease |
01/10/2001 | EP1066033A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
01/10/2001 | CN1279687A Bi-and tri-cyclic nucleoside, nucleotide and oligonucleotide analoguse |
01/10/2001 | CN1279671A Pyrazolylpyrazoles substituted by 1-methyl-5-alkylsulphonyl, 1-methyl-5-alkylsuphinyl and 1-methyl-5-alkylthio, methods for preparing them and use as herbicides |
01/10/2001 | CN1279604A Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration. |
01/09/2001 | US6171777 Decontaminating by contacting with compound, then recovering product; deactivates human immunodeficiency and hepatitis viruses; before transfusions or clinical tests |
01/04/2001 | DE19930111A1 New C-21 modified epothilone derivatives useful for treating e.g. cancer and other proliferative diseases and inhibiting angiogenesis and inducing apoptosis |
01/03/2001 | EP1065210A1 Novel xanthone compounds, their preparation and use as medicament |
01/03/2001 | EP1064285A1 Novel cephalotaxane derivatives and process for their preparation |
01/03/2001 | CN1278825A Sarcodictyin and eleutherobin useful for stabilising microtubules |
01/03/2001 | CN1278824A Novel substance FT-0554 and process for producing same |
01/03/2001 | CN1060174C Rifinement of pyromellitic acid dianhydride by hot air carrying process |
01/03/2001 | CN1060165C Crowndaisy chrysantheins compound |
12/28/2000 | WO2000078766A1 Difuropyrone derivatives |
12/28/2000 | WO2000078743A2 Preparation and use of gamma-butyrolactones as cross-linking agents |
12/28/2000 | WO2000078724A2 Imidazolinderivatives their preparation and their pharmaceutical use |
12/28/2000 | WO2000049021A3 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use |
12/28/2000 | WO2000047584A3 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals |
12/28/2000 | WO2000043373A3 Kinase inhibitors |
12/28/2000 | CA2375275A1 Difuropyrone derivatives |
12/28/2000 | CA2368846A1 Preparation and use of gamma-butyrolactones as cross-linking agents |
12/27/2000 | EP1062840A1 Apparatus and method for a custom soft-solid hearing aid |
12/27/2000 | EP0832054B1 Heterocyclic methyl free radicals as image enhancing agents |
12/26/2000 | CA2183453C Antiparasitic agents |
12/21/2000 | WO2000077007A1 Benzopyrans annelated in c7-c8 with an aromatic heterocycle and compositions and (co)polymer matrices containing them |
12/21/2000 | WO2000076961A1 Inhibitors of aspartyl protease |
12/21/2000 | CA2375867A1 Benzopyrans annelated in c7-c8 with an aromatic heterocycle and compositions and (co)polymer matrices containing them |
12/20/2000 | EP1060639A1 Compliant hearing aid and method of manufacture |
12/20/2000 | EP0714295B1 Fibrinogen receptor antagonists |
12/19/2000 | US6162931 Fluorinated xanthene derivatives |
12/19/2000 | US6162479 Citrus based spiro ethers as anti-fast-pass effect agents used as dietary supplement or medical food |
12/14/2000 | WO2000075125A1 Noninvasive imaging of nucleic acid vectors |
12/13/2000 | EP1058711A1 Bicyclooctane derivatives as plasticisers |
12/13/2000 | EP1058679A1 Synthesis of epothilones, intermediates thereto and analogues therof |
12/13/2000 | CN1276791A Macrolides with antitumor activity |
12/13/2000 | CN1059501C Protective cover for display devices comprising high-hard transparent resin |
12/12/2000 | US6160184 A chemical intermediate for forming a drug treating cancer |
12/12/2000 | US6160133 Stereospecific biosynthesis of the alcohol by enzymatic reduction of the corresponding aldehyde or ketone using a candida, zygosaccaromyces, or mortierrela microorganism |
12/12/2000 | US6160131 Repeatedly recrystallizing in polar organic solvent a solid which remains after nonpolar solvent extraction of a natural latex with a non-polar organic solvent |
12/12/2000 | US6160004 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities |
12/12/2000 | US6159932 Avermectin macrocyclic lactones and peptides |
12/12/2000 | US6159507 Food composition containing an omega-6/omega-3 unsaturated fatty acid balance modifier |
12/07/2000 | WO2000073310A1 4-substituted milbemycin derivatives |
12/07/2000 | WO2000072841A1 Compounds and methods for the treatment of post traumatic stress disorder |
12/07/2000 | WO2000031247A3 Recombinant methods and materials for producing epothilone and epothilone derivatives |
12/07/2000 | CA2374175A1 Compounds and methods for the treatment of post traumatic stress disorder |
12/07/2000 | CA2372240A1 4-substituted milbemycin derivatives |
12/06/2000 | EP1056717A1 Arylphenyl-substituted cyclic keto-enols |
12/06/2000 | EP1056453A1 Use of epothilones for the treatment of cancer |
12/06/2000 | EP1056450A1 Farnesyl-protein transferase inhibitors |
12/05/2000 | US6156905 Deoxy epothilones and intermediates utilized in the process for preparing epothilones |
12/05/2000 | US6156790 Anticarcinogenic agents and antitumor agents |
12/05/2000 | US6156769 Antipruitus drugs for mammals |
12/05/2000 | US6156282 Crown calix[4]arenes, method of preparation and use for selective extraction of caesium |
11/30/2000 | WO2000071556A1 Prodrug activation using catalytic antibodies |